Franklin Resources’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-439,809
Closed -$1.76M – 2360
2022
Q3
$1.76M Sell
439,809
-8,514
-2% -$64.6K ﹤0.01% 1388
2022
Q2
$5.07M Buy
448,323
+192,734
+75% +$2.31M ﹤0.01% 1107
2022
Q1
$4.15M Buy
255,589
+217
+0.1% +$5.56K ﹤0.01% 1204
2021
Q4
$12.1M Buy
255,372
+1,393
+0.5% +$83.6K ﹤0.01% 1005
2021
Q3
$18.4M Buy
253,979
+17,712
+7% +$1.28M 0.01% 910
2021
Q2
$19.8M Sell
236,267
-50,405
-18% -$3.33M 0.01% 859
2021
Q1
$13.9M Buy
286,672
+251,706
+720% +$13.7M 0.01% 916
2020
Q4
$1.65M Hold
34,966
– – ﹤0.01% 1327
2020
Q3
$1.64M Hold
34,966
– – ﹤0.01% 1266
2020
Q2
$1.05M Hold
34,966
– – ﹤0.01% 1268
2020
Q1
$455K Buy
+34,966
New +$437K ﹤0.01% 1330

Other funds holding NBP

Franklin Resources's NBP Position: Q4 2022 in Review

Franklin Resources sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 439,809 shares — an estimated $1.76M sold.

Franklin Resources first reported a position in NBP in Q1 2020 and held it in 11 quarters. The position peaked at $19.8M in Q2 2021. 68 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • Franklin Resources reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Franklin Resources sold 439,809 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $1.76M.
  • Franklin Resources first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 11 quarters.
  • Franklin Resources's NovaBridge Biosciences American Depositary Shares position peaked at $19.8M in Q2 2021.
  • 68 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.